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OBJECTIVES The aim of this study was to evaluate: 1) the effects of insulin administration on left
ventricular ejection fraction (LVEF) during exercise, and 2) the eventual impairment of the
cardiovascular response to insulin in noninsulin dependent diabetes mellitus.
BACKGROUND Insulin influences the cardiovascular system, but its effect on left ventricular function has yet
to be established.
METHODS The effects of normal saline (test A) and insulin-glucose (insulin 5 1.7 mUzkg21zmin21;
glucose 5 6 mgzkg21zmin21) (test B) infusions on systolic and diastolic functions at rest and
during dynamic exercise were examined by radionuclide ventriculography. Twenty-two
noninsulin-dependent diabetic patients and 22 gender, age and body mass index matched
healthy subjects were investigated.
RESULTS Both groups had normal scintigraphic parameters at rest and during dynamic exercise. Rest-
and stress-LVEF as well as rest- and stress-peak filling rate were significantly (p , 0.001)
lower in diabetic than in healthy subjects, both in test A and B. Rest-LVEF was significantly
higher during test B than it was in test A only in diabetic subjects (p , 0.01). Stress-LVEF
was significantly higher (p , 0.05) during test B than it was in test A, in both groups.
Insulin-glucose infusion did not modify rest- and stress-peak filling rate in either group. No
difference in left ventricular end diastolic volume and in mean blood pressure was found
between test A and B at rest and during exercise in either group. A significant linear
correlation between LVEF and the index of insulin sensitivity was found in diabetic patients.
CONCLUSIONS In both normal and diabetic humans, insulin induces a very important rise in LVEF after
submaximal work. However, the rise is significantly lower in diabetic than in nondiabetic
subjects. The increase in exercise-LVEF on insulin is likely due to an enhancement of
ventricular contractility. Insulin resistance could justify the lower angioscintigraphic indexes
in diabetic subjects. (J Am Coll Cardiol 2000;36:219–26) © 2000 by the American College
of Cardiology
Various clinical and experimental studies have documented
the influence of insulin on cardiac function. A direct
inotropic effect of insulin on the myocardium has been
demonstrated in cats (1) and lambs (2). In humans, a rise in
left ventricular ejection fraction (LVEF) measured by ra-
dionuclide ventriculography has been observed in patients
with acute myocardial infarction in response to a therapeutic
regimen containing glucose, insulin and potassium given by
intravenous infusion (3) although it is not known which
constituent provokes the cardiac effect. A significant rise in
LVEF was found by Fisher et al. (4) within 5 min of the
intravenous injection of insulin, before any measurable
change in the blood glucose concentration had occurred.
Avasthi et al. (5) reported significant increments in cardiac
output after ingestion of mixed meals when circulating
insulin levels physiologically rise. Baron et al. (6,7) recently
established that physiological insulin concentrations lead
under both steady-state and after an oral glucose load to
significant increments in cardiac output and that this effect
is impaired in insulin-resistant obese humans.
In this novel area of human research, two aspects have not
been investigated until now: 1) the effects of insulin admin-
istration on LVEF during exercise, 2) the eventual impair-
ment of the cardiovascular response to insulin in noninsulin
dependent diabetes mellitus (NIDDM), a condition noto-
riously associated with insulin resistance.
This study aimed to explore these topics. Cardiac func-
tion was examined in healthy subjects and NIDDM patients
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using resting and exercise radionuclide ventriculography
during both saline and double insulin-glucose infusion at
prefixed rates.
METHODS
Subjects. The study was approved by the medical ethical
committee of the Second University of Naples. Two groups
of subjects (Table 1) were studied after informed consent
was obtained: 22 NIDDM patients and 22 gender- age- and
body mass index matched healthy volunteers, with normal
75g oral glucose tolerance and negative family history for
NIDDM. Diabetic patients were in good metabolic control
as judged by glycosilated hemoglobin (HbA1c) levels with
diet and oral hypoglycaemic agents (glybenclamide:
10–15 mg per day).
An accurate preliminary evaluation was carried out with
the aim of minimizing the influence of factors other than
diabetes on left ventricular function. No subject had signs,
symptoms or history of heart disease, chronic alcoholism,
anemia, electrolyte imbalances, hepatic or endocrine or renal
diseases. Only subjects without risk factors for coronary
artery disease other than diabetes were selected. All partic-
ipants were nonsmokers and had blood pressure values
,140/90 mm Hg, serum cholesterol ,7.5 mmol/l, serum
tryglycerides ,1.8 mml/l and negative family history for
coronary artery disease.
Subjects with ECG abnormalities at rest or with
downsloping or horizontal ST segment depression during a
treadmill maximal exercise electrocardiography performed
according to the Bruce protocol (8) or with left ventricular
segmental asynergy assessed by M-mode and two-
dimensional echocardiography or with rest or stress myo-
cardial perfusion imaging performed after infusion of 3 mCi
of 201mT1 suggestive of ischemic heart disease were not
enrolled.
Microangiopathy was excluded by ophtalmological eval-
uation using direct fundoscopy within one month before the
study and by measuring excretion of albumin on a timed
24-h collection of urine (all subjects studied had albumin
excretion ,20 mg/24 h).
No difference in autonomic neural function was detected
between nondiabetic and diabetic subjects as assessed by the
heart rate responses to deep breathing, to Valsalva maneuver
and to standing and by the blood pressure response to
standing (Table 2). These tests were in age-related normal
ranges (9) for all subjects. Peripheral neuropathy was not
evaluated, as it had no influence on left ventricular function
(10).
Both healthy and diabetic groups were engaged in similar
physical activity. None of the participants were taking any
drugs other than glybenclamide.
Protocol. Each group underwent two multiple-gated ra-
dionuclide ventriculographies, one during infusion of nor-
mal saline (test A) and the other during a double insulin-
glucose infusion at prefixed rates (insulin 5 1.7
mUzkg21zmin21; glucose 5 6 mgzkg21zmin21) (test B). The
studies were randomly performed on two different occa-
sions, five to seven days apart.
The consumption of glybenclamide, alcohol, tea and
coffee was avoided for 12 h before and during each experi-
ment.
Subjects were studied in the supine position in a quiet
room at 20°C after an overnight 14-h fast.
The left arm was utilized for blood pressure measure-
ments, using a mercury sphygmomanometer with systolic
and diastolic blood pressures measured at Korotkoff’s 1st
and 5th sounds, respectively. Mean blood pressure (MBP)
was calculated from the sum of diastolic blood pressure plus
one-third of the arterial pulse pressure.
For the blood samples, a venous cannula was inserted
retrograde in a right hand vein and flushed with saline at a
rate of 0.5 mlzmin21, the hand being maintained in a hand
warmer at 65°C. For the infusions, a second cannula was
inserted in a vein of the antecubital fossa of the same side.
In test B, insulin (Humulin R; Ely Lilly, Basingskoke,
United Kingdom) was diluted in albumin, and normal saline
was added to obtain a concentration of 1.7 mU per kg of
patient body weight per milliliter, and a 50% dextrose
solution was diluted with normal saline to obtain a concen-
tration of 6 mg per kg of patient body weight per ml and
added with K2HPO4 (;0.0038 mezKg
21zml) to prevent
hypokalemia and hypophosfatemia. Both solutions were
infused at a rate of 1 ml per min.
Abbreviations and Acronyms
ANOVA 5 analysis of variance
ISI 5 insulin sensitivity index
LVEDV 5 left ventricular end diastolic volume
LVEF 5 left ventricular ejection fraction
MBP 5 mean blood pressure
MCR-G 5 metabolic clearance rate of glucose
MCR-I 5 metabolic clearance rate of insulin
NIDDM 5 noninsulin-dependent diabetes mellitus
PFR 5 peak filling rate
SS-G 5 steady-state plasma glucose
SS-I 5 steady-state plasma insulin










Healthy subjects (n 5 22) 39.8 6 1.9 11/11 24.8 6 0.9 4.4 6 0.3
Diabetic subjects (n 5 22) 40.6 6 1.8 11/11 25.2 6 0.9 3.9 6 0.8 6.6 6 0.2*
*p , 0.001.
BMI 5 body mass index.
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Test A was performed by infusing normal saline at a rate
of 2 ml per min to give the same fluid load as test B.
After obtaining a basal blood sample, insulin-glucose
infusion (test B) was started and maintained for 120 min to
achieve the steady-state condition. Infusion was maintained
for 120 min also during test A.
Successively, scintigraphic acquisition at rest was made
and, then, exercise started without stopping the saline or
insulin-glucose infusion until completion of stress scinti-
graphic scan.
The stress consisted of supine dynamic exercise on a
bicycle ergometer, beginning with 25 W at 60 rpm and
increasing by 25 W steps over 2 min until reaching the 75
W load. This work was maintained for 4 min for the stress
scintigraphic scan.
During exercise, the subjects were submitted to ECG-
standard recordings every 2 min.
For radionuclide angiography, red blood cells were la-
belled “in vivo” with 25 mCi of 99mTc pertechnetate. The
studies were carried out with a small field of view Gamma
camera (Basicam SIEMENS, Erlangen, Germany)
equipped with a low-energy, general purpose, parallel hole
collimator. Energy discrimination was provided by a 20%
window centered over the 140-keV photopeak of 99mTc. A
five million count study was made in 45° left anterior
oblique view with a 15° of caudal tilt, using the positioning
of the camera, which maximized the separation of blood
pool activity in the left and right ventricles. Data were
acquired in frame-mode by computer-based electrocardio-
graphic gating with a 1.53 digital zoom. The cardiac cycle
was divided into 24 frames, and data for each frame were
collected in a 64 3 64 matrix. The imaging rate was 50
frames/s (or 20 ms/frame) with a gate tolerance of 65%.
Left ventricular ejection fraction and peak filling rate (PFR)
were calculated by a standard computed software (11,12).
Left ventricular end diastolic volume (LVEDV) was calcu-
lated by the Massardo et al. (13) method. Angioscinti-
graphic parameters were evaluated at rest and at 75 W.
Blood samples for glucose, potassium and insulin deter-
minations were taken at 0, 30, 60, 90, 100, 110 and 120 min
and at the end of each work step. Plasma C-peptide levels
were measured at 0 and 120 min only during test B to
calculate the metabolic clearance rate of insulin. Plasma
adrenaline and noradrenaline levels were assessed at rest, at
the steady-state condition and at the end of the last work
step in both tests.
Heart rate (from electrocardiogram) and blood pressure
values were taken at basal conditions, before starting exer-
cise and every 2 min during dynamic exercise. Each blood
pressure determination was an average of at least two
measurements.
Calculations, analytic methods and statistics. Steady-
state (90–120 min) plasma glucose (SS-G), steady-state
plasma insulin (SS-I), metabolic clearance rate of glucose
(MCR-G), insulin sensitivity index (ISI 5 MCR-G/SS-
Iz100) and metabolic clearance rate of insulin (MCR-I)
were calculated for test B, as elsewhere reported (14).
Plasma glucose was measured by a glucose oxidase
method (Beckman glucose analyzer II, Fullerton, Califor-
nia). Plasma insulin and C-peptide were assayed with
radioimmunological technique using specific kits (INCSTAR
Corporation, Stillwater, Minnesota). Plasma adrenaline and
noradrenaline concentrations were determined by high per-
formance liquid chromatography. Glycosylated hemoglobin
A1c was determined by column chromatography using a
commercial kit (BIO-RAD, Hercules, California) (values
less than 7.0% indicated good glycemic control in diabetic
patients). Urine albumin was measured by radioimmunoas-
say technique; the lowest detection limit was 1.5 mg/ml.
Statistical analysis was made by one-way analysis of
variance (ANOVA). When differences were significant,
Student t tests for paired and unpaired data were performed.
Effect of insulin on angioscintigraphic parameters in dia-
betic and healthy subjects was analyzed by multivariate
two-way ANOVA with repeated measures. Simple regres-
sion was applied to evaluate correlations between ISI and
scintigraphic parameters. The computer software package
SPSS for Windows, version 7.5, was used.
The level of statistical significance chosen was p , 0.05.
Data in the text and Tables 1 through 5 are expressed as
mean 6 SD.
RESULTS
During investigations, plasma glucose concentration was
approximately kept at baseline, and none of the subjects
experienced hypoglycemia (plasma glucose ,2.8 mmol/l),
chest pain or electrocardiographic abnormalities suggestive
of myocardial ischemia. Regional wall motion during radio-













Healthy subjects 1.24 6 0.04 1.39 6 0.05 1.53 6 0.05 3.2 6 2.1 7.9 6 2.4
Diabetic subjects 1.22 6 0.04 1.37 6 0.04 1.52 6 0.06 3.8 6 1.7 8.2 6 2.7
Autonomic neural function was assessed by four cardiac reflex tests: 1) heart rate response to standing (30:15 ratio), 2) heart rate
response to the deep breathing at six breaths per min with calculation of the ratio of the longer RR-interval during expiration
and the shortest RR-interval during inspiration, 3) the Valsalva maneuver and calculation of the ratio of the longest RR-interval
after and the shortest RR-interval during the maneuver, 4) blood pressure response to standing.
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nuclide angiography was normal in all subjects at rest or in
response to exercise.
During exercise, patients and controls achieved 75% to
80% of the maximal ideal heart rate.
Metabolic/hormonal parameters. Test A (Fig. 1). Plasma
glucose was significantly (p , 0.001) higher in diabetic than
it was in healthy subjects during the whole test duration.
Plasma insulin levels in diabetic patients were at all times
significantly (p , 0.001) more elevated than it was in
healthy subjects.
Test B (Fig. 2). Plasma glucose was significantly (p ,
0.001) higher in diabetic than it was in healthy subjects
during the entire test duration. Plasma insulin levels were
significantly (p , 0.05 or less) higher in diabetic subjects at
all times.
Basal and 120-min C-peptide levels were significantly
(p , 0.05 or less) higher in diabetic subjects. Steady-state
plasma glucose and SS-I were significantly (p , 0.01 or less)
higher, whereas MCR-G, MCR-I and ISI were signifi-
cantly (p , 0.01 or less) lower in diabetic subjects (Table 3).
Test A versus test B. Neither group experienced any
significant difference between plasma glucose values during
test A and B. Plasma insulin levels were significantly higher
during insulin glucose-infusion (test B) than it was during
saline infusion (test A) in both groups.
Similar rest and stress noradrenaline and adrenaline
responses were observed between controls and diabetics in
both tests (Table 4).
No significant difference in serum K1 levels between
groups was found during test A and B and between tests.
Angioscintigraphic parameters. Each healthy and diabetic
subject showed a normal (.50%) LVEF at rest.
Diabetic versus healthy subjects (Table 5). During test A,
resting and exercise-LVEF, resting and exercise-PFR and
change in LVEF were significantly (p , 0.001) lower in
Figure 1. Insulin and glucose plasma levels during saline infusion (test A).
*p , 0.001.
Figure 2. Insulin and glucose plasma levels during insulin-glucose infusion
(test B). §p , 0.05; †p , 0.01; *p , 0.001.
Table 3. Hormonal/Metabolic Parameters During Insulin-
Glucose Infusion (Test B)
Healthy Subjects Diabetic Subjects
SS-G (mmol/L) 4.03 6 0.53 7.93 6 2.15‡
MCR-G (mg/kg/min) 9.1 6 1.0 4.1 6 1.2‡
SS-I (pmol/L) 789.1 6 70.1 870.3 6 122.4†
ISI 8.2 6 1.0 3.2 6 0.9‡
Basal CP (nmol/L) 0.85 6 0.3 1.30 6 0.51*
120 min CP (nmol/L) 0.74 6 0.31 1.32 6 0.43†
MCR-I (mU/kg/min) 17.1 6 1.3 13.4 6 1.4†
SS-G 5 steady-state plasma glucose; MCR-G 5 metabolic clearance rate of glucose;
SS-I 5 steady-state plasma insulin; ISI 5 insulin sensitivity index; CP 5 plasma
C-peptide; MCR-I 5 metabolic clearance rate of insulin.
*p , 0.05; †p , 0.01; ‡p , 0.001.
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diabetic subjects. No significant difference was found for
rest-LVEDV and stress-LVEDV between the two groups.
During test B, resting and exercise-LVEF, resting and
exercise-PFR and change in LVEF were significantly (p ,
0.001) lower in diabetic subjects; the other parameters did
not significantly differ between groups.
A significant positive correlation was found in diabetic
patients between LVEF and ISI both at rest (r 5 0.59; p ,
0.004) and during exercise (r 5 0.58; p , 0.005) (Fig. 3).
Test A versus test B (Table 5). Rest-LVEF was signifi-
cantly higher during test B than test A in diabetic subjects
(p , 0.01) but not in healthy subjects. Stress-LVEF was
significantly higher (p , 0.05 or less) during test B than A,
in both groups. Change in LVEF was significantly (p ,
0.001) higher in healthy subjects and significantly (p ,
0.01) lower in diabetic patients during test B. The differ-
ences in the other parameters were statistically insignificant
for both groups.
Two-way repeated measures ANOVA (Table 6). The study
of interaction between test A versus test B and diabetic
versus healthy subjects showed that the effect of insulin in
diabetic and healthy subjects was statistically different (p ,
0.0001) in rest-LVEF, stress-LVEF and change in LVEF.
Heart rate and blood pressure. No significant difference in
heart rate or MBP was found between healthy and diabetic
subjects in test A and B and between test A and B.
DISCUSSION
This study primarily aimed to explore the effect exerted by
a double infusion of insulin and glucose at prefixed rates on
Figure 3. Relation between LVEF and ISI both at rest (top) and during
exercise (bottom) in diabetic patients.
Table 4. Adrenaline and Noradrenaline Levels (nmol/l) During
Saline (Test A) and Insulin-Glucose (Test B) Infusions
Adrenaline
Healthy Subjects Diabetic Subjects
Test A
rest 0.443 6 0.135 0.409 6 0.089
stress 1.018 6 0.084 0.870 6 0.101
Test B
rest 0.476 6 0.123 0.401 6 0.085
stress 1.051 6 0.098 0.934 6 0.102
Noradrenaline
Healthy Subjects Diabetic Subjects
Test A
rest 0.391 6 0.072 0.473 6 0.161
stress 1.520 6 0.131 1.571 6 0.190
Test B
rest 0.403 6 0.082 0.493 6 0.173
stress 1.590 6 0.143 1.552 6 0.181
Table 5. Angioscintigraphic Parameters During Saline (Test A)
and Insulin-Glucose (Test B) Infusions
Test A
Healthy Subjects Diabetic Subjects
rest-LVEF (%) 67.0 6 2.8 57.2 6 2.0*
stress-LVEF (%) 72.3 6 1.8 63.6 6 2.6*
Change in LVEF 5.8 6 1.6 6.4 6 1.8*
rest-LVEDV (ml) 106.7 6 6.0 112.1 6 6.9
stress-LVEDV (ml) 94.3 6 12.3 100.1 6 13.5
rest-PFR (LVEDV/s) 2.8 6 0.4 2.1 6 0.4*
stress-PFR (LVEDV/s) 6.8 6 1.9 4.7 6 1.0*
Test B
Healthy Subjects Diabetic Subjects
rest-LVEF (%) 69.5 6 1.7 64.6 6 2.0*†
stress-LVEF (%) 81.9 6 1.5‡ 70.0 6 2.7*§
Change in LVEF 12.0 6 1.6‡ 5.4 6 1.3*†
rest-LVEDV (ml) 106.8 6 6.9 115.3 6 11.4
stress-LVEDV (ml) 98.3 6 9.8 102.4 6 14.6
rest-PFR (LVEDV/s) 2.8 6 0.3 2.2 6 0.4*
stress-PFR (LVEDV/s) 6.3 6 2.0 4.8 6 1.2*
LVEF 5 left ventricular ejection fraction; change in LVEF 5 variation of LVEF on
exercise; LVEDV 5 left ventricular end diastolic volume; PFR 5 peak filling rate.
*p , 0.001 (healthy vs. diabetic subjects); †p , 0.01; ‡p , 0.001 (test A vs. test
B); §p , 0.05.
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cardiac function at rest and in response to supine dynamic
exercise in healthy and NIDDM subjects.
The results seem to indicate that, in healthy subjects,
supraphysiological plasma levels of insulin are able to
substantially increase LVEF in response to submaximal
dynamic exercise, whereas they do not influence this param-
eter at rest. An echocardiographic study (15) has also shown
that moderate hyperinsulinemia, induced by intravenous
insulin infusion with euglycemic clamp technique, has no
effect on ejection phase indexes in healthy supine subjects.
Conversely, there is no data in the literature concerning
insulin’s effect on left ventricular function during dynamic
stress.
Cardiovascular effects of insulin. The mechanism under-
lying the cardiovascular effects of insulin and their evalua-
tion are complex. In agreement with some authors (16) but
not with others (17), we found no difference in left ventric-
ular end diastolic volume or in blood pressure between saline
and insulin-glucose infusion. Thus, an influence of preload
or afterload on LVEF can be reasonably excluded, and the
observed modifications of LVEF on insulin likely express
the status of left ventricular contractility.
In agreement with the literature (18–20) diabetic patients
showed an impaired diastolic function compared with
healthy subjects, both at rest and during exercise, as evalu-
ated by PFR. Moreover, insulin-glucose infusions do not
modify these diastolic parameters in either group.
The first question to be addressed is whether the increase
in ejection fraction during exercise observed for insulin is an
expression of the hormone’s direct action on the heart.
The similar heart rate changes from rest to exercise with
or without insulin-glucose infusion do not suggest changes
in sympathetic drive, as confirmed by plasma catecholamine
levels.
A direct inotropic effect of insulin has been suggested by
some authors. Experimental studies on cats and lambs have
shown that intravenous insulin increases myocardial con-
tractility, without being mediated by glucose or catechol-
amine (1,2). However, studies on dogs and rats have failed
to demonstrate a positive inotropic effect in either intact
hearts or isolated cardiac muscle (21–23).
Metabolic hypothesis. We hypothesize that enhanced left
ventricular function observed after insulin may be due to the
metabolic effects of the hormone. In resting fasting humans,
heart muscle takes up significant amounts of free fatty acids,
lactate, pyruvate, glycerol and beta-hydroxybutyrate, that is,
it preferentially uses substrates that yield energy through
mitochondrial metabolism, while glycolysis normally pro-
duces only ;30% of energy (24–28). Physiological hyper-
insulinemia specifically enhances myocardial glucose, lactate
and pyruvate uptake, converting cardiac fuel reliance from
fat to carbohydrate (16). A similar shift of circulating
substrate uptake and oxidation by the heart has been
observed during atrial pacing (29). Conversely, during
exercise lactate becomes the most important source of
energy for the heart (26). These findings suggest that
hyperinsulinemia during dynamic stress may increasingly
favor myocardial carbohydrate oxidation and, consequently,
improve cardiac performance in healthy subjects.
Role of diabetes on systolic function. The noninsulin-
dependent diabetic patients we examined by radionuclide
angioscintigraphy showed normal LVEF and normal rise in
this parameter on supine dynamic exercise. Nevertheless,
their LVEF at rest and under stress and both on saline or
insulin was significantly lower than that of a healthy
population matched for age, gender and body mass index.
Our diabetic patients were relatively young; disease du-
ration was short, and they were in good metabolic control.
Moreover, coronary artery disease, microangiopathy, auto-
nomic neuropathy and any cardiovascular abnormalities
detectable by noninvasive techniques were excluded early.
Due to these strict exclusion criteria, it is reasonable that
only diabetes could have conditioned this depressed, albeit
normal, systolic function in the diabetic group. The use of
glybenclamide could have played a role. However, a
positive (rather than negative) inotropic effect on the
heart has been reported only for tolbutamide (30). In this
regard, no data are available for second and third gener-
ation sulphonylureas.
Unlike healthy subjects, the LVEF of diabetic patients
after insulin significantly increased not only during exercise
but even at rest. However, despite the higher steady-state
that plasma insulin levels reached during insulin-glucose
infusion (likely induced by their lower metabolic clearance
rate of the hormone), the diabetic group showed a signifi-
cant decline in the percent rise of the ejection fraction in
response to work.
These differences cannot be justified by the behavior of
afterload, preload or catecholamine levels.
If it is true that the increment of the exercise-LVEF on
insulin in healthy subjects is mediated by the metabolic
effects of the hormone, the lower angioscintigraphic indexes
observed in NIDDM subjects could be justified by their
insulin resistance, as suggested by the significant linear
correlation between LVEF and the ISI found in these
patients.
In diabetic patients at rest, insulin infusion partially
compensates the gap with the healthy subjects, by improv-
Table 6. Two-Way Repeated Measures ANOVA
Sources of Variability F
Rest-LVEF diabetic vs. healthy subjects 204.912
test A vs. test B 150.118
interaction 64.369*
Stress-LVEF diabetic vs. healthy subjects 354.245
test A vs. test B 437.517
interaction 18.711*
Change in LVEF diabetic vs. healthy subjects 58.414
test A vs. test B 80.685
interaction 144.496*
*p , 0.0001.
ANOVA 5 analysis of variance.
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ing the yield of metabolic glucose pathways and cardiac
performance. In the same patients, the stress-induced in-
crease of LVEF is, conversely, less important during insulin
than during saline infusion, perhaps because of overbur-
dened heart glucose metabolism.
Metabolism in the diabetic heart. This may be in agree-
ment with the finding of metabolic defects within myocar-
dial postreceptors in a streptozotocin-induced rat model of
NIDDM, which lead to a significant basal and insulin-
stimulated reduction in glucose oxidation and ATP synthe-
sis from glucose (31) and a parallel decrease in the maximal
stimulation of cardiac work by insulin (32). However,
studies on humans utilizing positron emission tomography
to determine regional glucose utilization rates have failed to
document decreased glucose uptake in either type-1 (33) or
type-2 (34) diabetic patients, despite a reduced rate of whole
body glucose uptake. Thus, skeletal muscle and heart insulin
resistance do not seem to coexist. These findings do not
exclude defects within successive steps of carbohydrate
oxidation, which may limit the rate of glycolysis and the
Krebs cycle in the diabetic heart. It has been found that
insulin has an independent effect on lactate oxidation in the
canine heart, suggesting the direct activation of pyruvate
dehydrogenase (35). Ferrannini et al. (16) observed in
humans that physiological hyperinsulinemia increases the
heart’s lactate extraction rate more than two-fold. Based on
these data, a defect of pyruvate dehydrogenase may be
hypothesized in the diabetic heart, and the cardiac insulin
resistance may be suggested as a possible background factor
for the development of the “diabetic cardiomyopathy” in
type-2 diabetes.
In conclusion, our study is the first to show that supra-
physiological levels of circulating insulin in normal humans
do not modify LVEF at rest, but significantly increase it in
response to a submaximal work, as assessed by radionuclide
ventriculography. In noninsulin-dependent diabetic sub-
jects, this increment also occurs at rest, even when both rest
and stress-LVEF appear to be significantly lower in this
population than it is healthy subjects. Further investigations
need to interpret the physiological mechanisms and signif-
icance of the synergy between exercise and insulin on LVEF
and confirm the eventual relationship between insulin re-
sistance in the heart and the left ventricular systolic hypo-
function in NIDDM.
Reprint requests and correspondence: Dr. Ferdinando Carlo
Sasso, Via A. Fontana, 81 (Parco Lamaro, Palazzina 15), Napoli,
Italy. E-mail: ferdinando.sasso@unina2.it.
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